Zoekresultaten - 7 results

Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment.

environmental risk assessment oncolytic virus shedding Abstract: Attenuated and/or genetically modified oncolytic viruses (OV) gain increasing interest as a promising approach for cancer therapy. Beside the ...

Biosafety of viral vectors commonly used in gene therapy and vaccination.

Publication Type: Peer reviewed scientific article Authors: Philippe Herman Source: Curr Gene Ther, Volume 13, Issue 6, p.383-4 (2013) Keywords: Genetic Therapy Genetic Vectors Hazardous Substances ...

Environmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.

Animals Clinical Trials as Topic Genetic Therapy Genetic Vectors Hazardous Substances Humans Risk Assessment Vaccination vaccinia virus Viral Vaccines Abstract: The modified vaccinia virus Ankara (MVA) ...

Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination.

Clinical Trials as Topic Gene Transfer Techniques Genetic Therapy Genetic Vectors Humans Mammals Neoplasms Poxviridae Infections Practice Guidelines as Topic Vaccination vaccinia virus Viral Vaccines ...

State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations.

transfer vehicles, as used for both research and gene therapy applications, because of their stable integration in non-dividing and dividing cells and long-term transgene expression. Along with our ...

Successful treatment with voriconazole of prolonged Paecilomyces lilacinus fungemia in a chronic hemodialyzed patient

0 adverse effects Agent Agents Antifungal Agents article Belgium blood Brussels Case case reports Catheter-Related Infections Catheters,Indwelling cause chronic culture de drug therapy Female Fungemia Human ...

QR code

QR code for this page URL